Indications for stereotactically-aided differential diagnosis: the neurologist's view

Area of Science:

• Neurology
• Neurosurgery
• Pathology

Background:

• Stereotactic biopsy (SB) offers a minimally invasive approach for tissue diagnosis.
• Craniotomy is often contraindicated in specific patient populations or lesion types.
• Accurate diagnosis is critical for effective treatment planning in neurological disorders.

Purpose of the Study:

• To review the utility of stereotactic biopsy (SB) across three distinct pathological categories.
• To highlight SB's role in diagnosing neoplastic disease, immunodeficiency states, and degenerative cerebral atrophy.
• To assess SB's value when conventional surgical methods are not feasible.

Main Methods:

• Review of existing literature and case studies on stereotactic biopsy.
• Analysis of SB's diagnostic accuracy in neoplastic, immunodeficient, and degenerative conditions.
• Comparison of SB with alternative diagnostic modalities where applicable.

Main Results:

• SB is the most reliable method for characterizing intracranial space-occupying lesions when craniotomy is contraindicated, determining malignancy and limits.
• In immunocompromised patients, SB effectively differentiates tumors from opportunistic infections.
• SB aids in distinguishing Alzheimer's disease from other degenerative conditions in dementia patients.

Conclusions:

• Stereotactic biopsy is an indispensable tool in neuro-oncology and diagnostic neurology.
• SB provides critical diagnostic information in challenging cases, improving patient management.
• The application of SB spans neoplastic disease, infectious processes, and neurodegenerative disorders.